Theravance BiopharmaTBPH
那斯達克 · USD
17.02
+0.08
(+0.47%)
收盤 05/08 03:59 (UTC+8)
05/08 03:59 (UTC+8)
Theravance BiopharmaTBPH
17.02
+0.08
(+0.47%)
財務數據
損益表
- 0.18
- 0.15
- 0.14
- 0.17
- 0.19
- 0.15
- 0.26
- 0.20
- 0.46
- 0.18
- 11.93
- -17.43
- -1.70
- 18.32
- 11.18
- -17.95
- 70.23
- -23.69
- 129.57
- -61.43
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 17,699 | 45,891 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | 14,503 | 17,565 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | 45,891 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | - | 17,565 |
營業費用 | - | 25,880 | 26,444 | 28,920 | 29,822 | 27,954 | 27,705 | 29,961 | - | 23,805 |
研發費用 | - | 7,360 | 8,112 | 10,490 | 11,452 | 9,453 | 9,268 | 9,954 | 8,968 | 8,313 |
推銷及管理費用 | - | 18,520 | 18,332 | 18,430 | 18,370 | 18,501 | 16,875 | 17,056 | 16,742 | 15,492 |
非經常性項目費用 | - | - | - | - | - | - | 1,562 | 2,951 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -9,483 | 20,011 | -6,454 | -2,725 | -14,434 | -9,200 | -10,837 | -15,705 | -11,207 | -6,240 |
其他收入及費用 | - | 53,639 | 4,138 | 76,594 | 939 | 904 | 1,415 | 1,128 | 1,434 | 1,847 |
利息費用 | - | 582 | 573 | 663 | 643 | 643 | 630 | 644 | 629 | 623 |
稅前純益 | -6,470 | 73,068 | -2,889 | 73,206 | -14,138 | -8,939 | -10,052 | -15,221 | -10,402 | -5,016 |
所得稅 | -1,537 | 12,044 | -6,504 | 18,371 | -559 | 6,588 | 2,646 | 1,308 | 1,262 | 3,494 |
稅後純益 | -4,933 | 61,024 | 3,615 | 54,835 | -13,579 | -15,527 | -12,698 | -16,529 | -11,664 | -8,510 |
基本每股稅後盈餘(元) | -0.10 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 |
稀釋每股稅後盈餘(元) | -0.10 | 1.18 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.19 |
基本平均股數(千股) | 51279.00 | 50868.00 | 50520.00 | 50177.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 | 49415.00 |
稀釋平均股數(千股) | 51279.00 | 53053.00 | 51908.00 | 50726.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 | 49415.00 |
還原基本每股稅後盈餘(元) | -0.10 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 |
還原稀釋每股稅後盈餘(元) | -0.10 | 1.18 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.19 |
還原基本平均股數(千股) | 51,279 | 50,868 | 50,520 | 50,177 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 | 49,415 |
還原稀釋平均股數(千股) | 51,279 | 53,053 | 51,908 | 50,726 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 | 49,415 |
EBITDA(千元) | -6,470 | 73,846 | -1,680 | 74,796 | -12,443 | -7,601 | -8,660 | -13,598 | -8,594 | -2,976 |